BioMarker Strategies LLC-Product Pipeline Analysis, 2017 Update

BioMarker Strategies LLC-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME38032PD
  • |
  • Pages: 29
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

BioMarker Strategies LLC (BioMarker Strategies) is a biotechnology company that develops tissue-based cancer diagnostic systems. The company offers cancer diagnostics system for predictive tests to targeted treatments for solid tumor malignancies. It also offers pathmap functional signaling profiles, which are a class of biomarker tests. BioMarker Strategies' snappath is used for predictive tests to guide targeted drug development and treatment selection. The company's pathmap profiles provide predictive tests to guid targeted drug development, information on signal transduction networks, which include pathway activation and feedback loops that predicts patient response to targeted drug therapy. Its products are used in early clinical studies for assessing pharmacodynamic changes in the solid tumors. BioMarker Strategies is headquartered in Rockville, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company BioMarker Strategies LLC

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

BioMarker Strategies LLC Company Overview 4

BioMarker Strategies LLC Company Snapshot 4

BioMarker Strategies LLC Pipeline Products and Ongoing Clinical Trials Overview 4

BioMarker Strategies LLC-Pipeline Analysis Overview 7

BioMarker Strategies LLC-Key Facts 7

BioMarker Strategies LLC-Major Products and Services 8

BioMarker Strategies LLC Pipeline Products by Development Stage 9

BioMarker Strategies LLC Pipeline Products Overview 11

Ex Vivo Biomarker Test-Breast Cancer 11

Ex Vivo Biomarker Test-Breast Cancer Product Overview 11

Ex Vivo Biomarker Test-Colon Cancer 12

Ex Vivo Biomarker Test-Colon Cancer Product Overview 12

Ex Vivo Biomarker Test-Lung Cancer 13

Ex Vivo Biomarker Test-Lung Cancer Product Overview 13

Ex Vivo Biomarker Test-Melanoma 14

Ex Vivo Biomarker Test-Melanoma Product Overview 14

Ex Vivo Biomarker Test-Pancreatic Cancer 15

Ex Vivo Biomarker Test-Pancreatic Cancer Product Overview 15

Ex Vivo Biomarker Test-Solid Tumors 16

Ex Vivo Biomarker Test-Solid Tumors Product Overview 16

PathMAP 17

PathMAP Product Overview 17

PathMAP NSCLC 18

PathMAP NSCLC Product Overview 18

BioMarker Strategies LLC-Key Competitors 19

BioMarker Strategies LLC-Key Employees 20

BioMarker Strategies LLC-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

BioMarker Strategies LLC, Recent Developments 22

Sep 19, 2016: BioMarker Strategies Awarded Phase I National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer 22

Jun 29, 2016: BioMarker Strategies Awarded Phase I/II Fast Track National Cancer Institute Grant to Develop Companion Diagnostic Test to Select Optimal Therapy for Patients with Non-Small Cell Lung Cancer 22

Jan 07, 2016: BioMarker Strategies Announces Issuance of Key Patents in the United States, Europe, Australia and Hong Kong 23

Jun 01, 2015: Dr. Samuel Broder, Former Director of the National Cancer Institute, Joins BioMarker Strategies as Chairman, Scientific Advisory Board 23

Sep 25, 2013: BioMarker Strategies Awarded $1.5 Million National Cancer Institute Contract to Develop Companion Diagnostic Test to Select Optimal Therapy for Melanoma Patients 24

Oct 03, 2012: BioMarker Strategies Appoints Jack Davis As Executive Chairman 24

May 27, 2011: BioMarker Strategies Appoints Glenn Miller To Board Of Directors As Chairman 24

Jan 03, 2011: BioMarker Strategies Appoints Three New Directors 25

Oct 07, 2009: NCI Grants Fast-Track SBIR Contract To BioMarker Strategies For Development Of SnapPath System 25

Jul 09, 2008: BioMarker Strategies Announces Executive Changes 25

Appendix 26

Methodology 26

About GlobalData 28

Contact Us 28

Disclaimer 28

List of Figures

BioMarker Strategies LLC Pipeline Products by Equipment Type 5

BioMarker Strategies LLC Pipeline Products by Development Stage 9

List of Tables

BioMarker Strategies LLC Pipeline Products and Ongoing Clinical Trials Overview 4

BioMarker Strategies LLC Pipeline Products by Equipment Type 5

BioMarker Strategies LLC Pipeline Products by Indication 6

BioMarker Strategies LLC, Key Facts 7

BioMarker Strategies LLC, Major Products and Services 8

BioMarker Strategies LLC Number of Pipeline Products by Development Stage 9

BioMarker Strategies LLC Pipeline Products Summary by Development Stage 10

Ex Vivo Biomarker Test-Breast Cancer-Product Status 11

Ex Vivo Biomarker Test-Breast Cancer-Product Description 11

Ex Vivo Biomarker Test-Colon Cancer-Product Status 12

Ex Vivo Biomarker Test-Colon Cancer-Product Description 12

Ex Vivo Biomarker Test-Lung Cancer-Product Status 13

Ex Vivo Biomarker Test-Lung Cancer-Product Description 13

Ex Vivo Biomarker Test-Melanoma-Product Status 14

Ex Vivo Biomarker Test-Melanoma-Product Description 14

Ex Vivo Biomarker Test-Pancreatic Cancer-Product Status 15

Ex Vivo Biomarker Test-Pancreatic Cancer-Product Description 15

Ex Vivo Biomarker Test-Solid Tumors-Product Status 16

Ex Vivo Biomarker Test-Solid Tumors-Product Description 16

PathMAP-Product Status 17

PathMAP-Product Description 17

PathMAP NSCLC-Product Status 18

PathMAP NSCLC-Product Description 18

BioMarker Strategies LLC, Key Employees 20

Glossary 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

BioMarker Strategies LLC, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53670
Site License
USD 1500 INR 107340
Corporate User License
USD 2250 INR 161010

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com